STING agonists reduce genital chlamydial infection and attenuate inflammation and pathology.

Unexpectedly, high-dose regimens did not abolish genital tract lesions; instead, they modestly increased both the incidence and severity of hydrosalpinx, although the difference did not reach statistical significance.

also in 111,027 other papers